WO2020211556A1 - 一种用于治疗糖尿病的中药及其制备方法 - Google Patents

一种用于治疗糖尿病的中药及其制备方法 Download PDF

Info

Publication number
WO2020211556A1
WO2020211556A1 PCT/CN2020/077786 CN2020077786W WO2020211556A1 WO 2020211556 A1 WO2020211556 A1 WO 2020211556A1 CN 2020077786 W CN2020077786 W CN 2020077786W WO 2020211556 A1 WO2020211556 A1 WO 2020211556A1
Authority
WO
WIPO (PCT)
Prior art keywords
parts
chinese medicine
weight
shell
diabetes
Prior art date
Application number
PCT/CN2020/077786
Other languages
English (en)
French (fr)
Inventor
杨德威
Original Assignee
杨德威
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 杨德威 filed Critical 杨德威
Publication of WO2020211556A1 publication Critical patent/WO2020211556A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Definitions

  • the invention relates to the technical field of diabetic treatment prescriptions, in particular to a traditional Chinese medicine for treating diabetes and a preparation method thereof.
  • Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by insulin secretion defects or impaired biological effects, or both. Clinical manifestations: (1) Polydipsia, polyuria, and polyphagia And weight loss, the typical symptoms of “three more and one less” appear when severe hyperglycemia occurs, which are more common in type 1 diabetes. The “three more and one less” symptoms are more obvious when ketosis or ketoacidosis occurs; (2) fatigue, weakness, Obesity is more common in type 2 diabetes; obesity is often seen before the onset of type 2 diabetes, and if it is not diagnosed in time, weight will gradually decrease.
  • Type 1 diabetes the age of onset is light, mostly younger than 30 years old, the onset is sudden, the symptoms of polydipsia, polyuria, and weight loss are obvious, and the blood sugar level is high. Many patients have ketoacidosis as the first symptom, serum insulin and C peptide Low levels, ICA, IAA or GAD antibodies can be positive, oral medication alone is ineffective, and insulin therapy is required.
  • Type 2 diabetes It is common in middle-aged and elderly people. The incidence of obesity is high.
  • the purpose of the present invention is to provide a traditional Chinese medicine for treating diabetes and a preparation method thereof, which solves the problems existing in the background technology and meets the needs of actual use.
  • a Chinese medicine for the treatment of diabetes Its raw materials are as follows by weight: 30 parts of Eclipta prostrata, 30 parts of Ligustrum lucidum, 15 parts of Cuscuta seeds, 15 parts of Bupleurum, 10 parts of tangerine peel, 10 parts of green peel, 5 parts of husk, 15 parts of Atractylodes macrocephala, 10 parts of Radix Paeoniae Alba, 10 parts of Cork, 15 parts of Turmeric, 15 parts of Rehmannia, 25 parts of Turtle Carapace, 25 parts of Golden Tortoise Shell.
  • the weight ratio of the Eclipta prostrata, Ligustrum lucidum, Cuscuta vulgaris, Bupleurum, orange peel, green peel, husk, Atractylodes macrocephala, white peony root, cork, turmeric, rehmannia, turtle shell, and golden tortoise shell is It can be combined with different weight ratios based on the simple symptoms, complications, and comorbidities that occur in the body of diabetic patients under the premise that the original prescription remains unchanged.
  • the preparation method of the traditional Chinese medicine for treating diabetes includes the following steps:
  • weight of the body 30 parts of Eclipta prostrata, 30 parts of Ligustrum lucidum, 15 parts of Cuscuta, 15 parts of Bupleurum, 10 parts of tangerine peel, 10 parts of green peel, 5 parts of husk, 15 parts of Atractylodes, 10 parts of white peony, 10 parts of Phellodendron amurense , 15 parts of turmeric, 15 parts of rehmannia, 25 parts of turtle shell, 25 parts of money turtle shell, Chinese medicinal materials are added;
  • S4 Use a filling machine to fill the mixed Chinese medicinal materials into a clean packaging bag, and use a vacuum packaging machine to pack and seal.
  • the stainless steel tank body is cleaned after use and irradiated with ultraviolet rays for 10-20 minutes, and sealed with a lid immediately after irradiation to prevent dust and bacteria from entering.
  • S4 checks whether the packaging bag is intact after the packaging is completed, and the unpackaged packaging tape is repackaged.
  • the present invention adopts Chinese medicinal materials for treatment, has no toxic and side effects, and does not damage the human body, is convenient for treatment, and can be taken for a period of time, which can significantly reduce the phenomenon of systemic complications caused by diabetes. .
  • the raw materials of the Chinese medicine for the treatment of diabetes are as follows by weight: 30 parts of Eclipta prostrata, 30 parts of Ligustrum lucidum, 15 parts of Cuscuta seed, 15 parts of Bupleurum, 10 parts of tangerine peel, 10 parts of green peel, 5 parts of husk, 15 parts of Atractylodes macrocephala, 10 parts of Radix Paeoniae Alba, 10 parts of Cork, 15 parts of Turmeric, 15 parts of Rehmannia, 25 parts of Turtle Carapace, 25 parts of Golden Tortoiseshell; wherein, the Eclipta prostrata, Ligustrum lucidum, Cuscuta, Bupleurum, Chenpi,
  • the weight ratio of green skin, shell, atractylodes, white peony, cork, turmeric, rehmannia, turtle shell, and golden tortoise shell can be based on the simple symptoms, complications, and comorbidities that occur in the body of diabetic patients under the premise that
  • the preparation method of the traditional Chinese medicine for treating diabetes includes the following steps:
  • weight of the body 30 parts of Eclipta prostrata, 30 parts of Ligustrum lucidum, 15 parts of Cuscuta, 15 parts of Bupleurum, 10 parts of tangerine peel, 10 parts of green peel, 5 parts of husk, 15 parts of Atractylodes, 10 parts of white peony, 10 parts of Phellodendron amurense , 15 parts of turmeric, 15 parts of rehmannia, 25 parts of turtle shell, 25 parts of money turtle shell, Chinese medicinal materials are added;
  • S4 Use a filling machine to fill the mixed Chinese medicinal materials into a clean packaging bag, and use a vacuum packaging machine to pack and seal (in S4, after the packaging is completed, check whether the packaging bag is intact and the packaging tape is not intact Repackage).
  • the stainless steel tank body is cleaned after use and irradiated with ultraviolet rays for 10-20 minutes, and sealed with a lid immediately after irradiation to prevent dust and bacteria from entering.
  • Clinical case Zhang Mou, 43 years old, suffering from diabetes. Symptoms include drinking and polyuria, myocardial infarction, vision loss, hearing loss, eating more and hunger, no insulin injection, fasting blood sugar 21, postprandial blood sugar 31, daily need Inject 16 units of insulin before meals for 28 days and take 2 to 3 units of insulin before meals every day. Symptoms are improved under normal appetite. After 9 months of continuous medication, only 1 unit of insulin is injected every day.
  • the preparation method of Chinese medicine for the treatment of diabetes not only has the effect of curing diabetes, because it is made of pure Chinese medicine, it also has other functions of Chinese medicine, such as:
  • Eclipta prostrata has the effects of nourishing liver and kidney, black hairs and teeth, cooling blood and stopping bleeding. Eclipta prostrata mainly treats liver and kidney deficiency, dizziness and tinnitus, dizziness of vision, weakness in waist and knees, white teeth shaking, and exertion. Turbidity, hemoptysis, vomiting blood, hemoptysis, hematuria, dysentery, uterine bleeding, traumatic bleeding.
  • Ligustrum lucidum nourishing liver and kidney, improving eyesight and black hair. It belongs to Yin tonic under the classification of tonic drugs.
  • Susizi It can nourish the liver and kidney, benefit the essence, improve eyesight, treat waist and knee pain, nocturnal emission, diminish thirst, have residual urine, and dark eyes. It is a commonly used medicine to nourish the kidneys and reduce urine and stop nocturnal emission. It is used for waists with insufficient liver and kidney. Sore knees, impotence, spermatorrhea. This product is soft and moisturizing, nourishes the liver and kidney without being dry.
  • Bupleurum clearing away heat and detoxifying, promoting blood circulation and promoting the urine of Hedyotis diffusa, used for tonsillitis, pharyngitis, urinary tract infection, pelvic inflammatory disease, appendicitis, hepatitis, bacillary dysentery, snake bites, tumors, can enhance the body's immunity and inhibit The growth of tumor cells.
  • White Peony It has the functions of softening the liver and relieving pain, hypochondriac pain, sedation and antibacterial, nourishing blood and restraining yin, and sweating.
  • Smilax glabra It has dehumidification and detoxification, and has a significant effect on muscle and bone contractions.
  • the Chinese medicine for treating diabetes prepared by the embodiment of the present invention randomly treats patients with several symptoms, and the obtained data are as follows:
  • the formula and preparation process adopted by the present invention make the essence of the traditional Chinese medicine composition have a better therapeutic effect on diabetic patients; in addition, the traditional Chinese medicine composition has very good penetration Sex, enhances appetite, so it has a certain therapeutic effect on patients with anorexia.
  • the present invention provides a Chinese medicine for the treatment of diabetes. Its raw materials are as follows by weight: 30 parts of Eclipta prostrata, 30 parts of Ligustrum lucidum, 15 parts of Cuscuta seeds, 15 parts of Bupleurum vulgare, 10 parts of tangerine peel, 10 parts of green peel, 5 parts of shell, 15 parts of Baizhu, 10 parts of white peony, 10 parts of cork, 15 parts of turmeric, 15 parts of rehmannia, 25 parts of turtle shell, 25 parts of golden turtle shell.
  • the invention adopts traditional Chinese medicinal materials for treatment, has no toxic side effects, does not damage the human body, is convenient for treatment, and can be taken for a period of time, which can obviously reduce the phenomenon of systemic complications caused by diabetes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种用于治疗糖尿病的中药及其制备方法。该中药的原料及重量份如下：旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、枳壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25份。该中药服用一段时间，可减轻糖尿病引起的全身并发症的现象。

Description

一种用于治疗糖尿病的中药及其制备方法 技术领域
本发明涉及糖尿病治疗方技术领域，具体涉及一种用于治疗糖尿病的中药及其制备方法。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病，高血糖则是由于胰岛素分泌缺陷或其生物作用受损，或两者兼有引起，临床表现：(1)多饮、多尿、多食和消瘦，严重高血糖时出现典型的“三多一少”症状，多见于1型糖尿病，发生酮症或酮症酸中毒时“三多一少”症状更为明显；(2)疲乏无力，肥胖多见于2型糖尿病；2型糖尿病发病前常有肥胖，若得不到及时诊断，体重会逐渐下降。糖尿病时长期存在的高血糖，导致各种组织，特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。其中，1型糖尿病：发病年龄轻，大多小于30岁，起病突然，多饮多尿多食消瘦症状明显，血糖水平高，不少患者以酮症酸中毒为首发症状，血清胰岛素和C肽水平低下，ICA、IAA或GAD抗体可呈阳性，单用口服药无效，需用胰岛素治疗。2型糖尿病：常见于中老年人，肥胖者发病率高，常可伴有高血压，血脂异常、动脉硬化等疾病，起病隐袭，早期无任何症状，或仅有轻度乏力、口渴，血糖增高不明显者需做糖耐量试验才能确诊，血清胰岛素水平早期正常或增高，晚期低下。胰岛素对糖尿病治疗方法非常不方便而且无法根治，而且治疗费用高。
发明内容
针对上述缺陷，本发明的目的是提供一种用于治疗糖尿病的中药及其制备方法，解决了背景技术存在的问题，满足实际使用需要。
本发明是通过以下技术方案实现的：
一种用于治疗糖尿病的中药，其原料按重量份如下：旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25。
作为上述技术方案的改进，所述旱莲草、女贞子、菟丝子、柴胡、陈皮、青皮、积壳、白术、白芍、黄柏、郁金、熟地、鳖甲、金钱龟板重量份比例为可按糖尿病患者身体所出现的单纯病症、并发症、合病等在原药方不变的前提下作不同重量比例配伍。
具体地，所述用于治疗糖尿病的中药的制备方法，包括如下步骤：
S1：按照重量份取中药原料，去除霉坏的中药材，再将中药材清洗干净，并自然风干使水含量于5至8％；
S2：清洗后将中药材原料分别置于粉碎机内粉碎处理，粉碎后过50至100目网，并将粉 碎后的中药材分别置于不同的密闭等重量的不锈钢罐体内，向该不锈钢罐体按照的重量旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25份关系添加中药材；
S3：将S2中不锈钢罐体内的中药材一同加入混料机中，混合10分钟；
S4：采用灌装机将混合后的中药材等重量的灌装入干净的包装袋中，并使用真空包装机包装封口。
作为上述技术方案的改进，所述不锈钢罐体使用后清洗干净并用紫外线照射10-20min，照射后立即用盖子密封，避免灰尘、细菌进入。
作为上述技术方案的改进，S4中包装结束后检查包装袋是否包装完好，未包装完好的包装带重新包装。
本发明的有益效果：本发明与常规治疗糖尿病的方法相比，采用中药材治疗，无毒副作用，而且不会损伤人体，治疗方便，服用一段时间，可明显减轻糖尿病引起的全身并发症的现象。
具体实施方式
实施例：
所述用于治疗糖尿病的中药，其原料按重量份如下：旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25；其中，所述旱莲草、女贞子、菟丝子、柴胡、陈皮、青皮、积壳、白术、白芍、黄柏、郁金、熟地、鳖甲、金钱龟板重量份比例为可按糖尿病患者身体所出现的单纯病症、并发症、合病等在原药方不变的前提下作不同重量比例配伍。
所述用于治疗糖尿病的中药的制备方法，包括如下步骤：
S1：按照重量份取中药原料，去除霉坏的中药材，再将中药材清洗干净，并自然风干使水含量于5至8％；
S2：清洗后将中药材原料分别置于粉碎机内粉碎处理，粉碎后过50至100目网，并将粉碎后的中药材分别置于不同的密闭等重量的不锈钢罐体内，向该不锈钢罐体按照的重量旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25份关系添加中药材；
S3：将S2中不锈钢罐体内的中药材一同加入混料机中，混合10分钟；
S4：采用灌装机将混合后的中药材等重量的灌装入干净的包装袋中，并使用真空包装机包装封口(S4中包装结束后检查包装袋是否包装完好，未包装完好的包装带重新包装)。
具体地，所述不锈钢罐体使用后清洗干净并用紫外线照射10-20min，照射后立即用盖子密封，避免灰尘、细菌进入。
临床案例：张某，43岁，患有糖尿病，症状表现为口喝多饮多尿，心肌梗塞,视力下降，听力下降，多吃善饥，不注射胰岛素空腹血糖21餐后血糖31，每天需在餐前注射胰岛素16个单位，服药28天，每天餐前胰岛素2至3个单位，在正常饭量的情况下症状改善，连续服药9个月后，每天只需注射1个单位的胰岛素。
服用方法：用水浸泡15至30分钟，加入总量3倍的水在砂锅或搪瓷锅中用大火煎煮至水滚开，再用小火煎煮30分钟，滤去药渣，取药汁即成。
该用于治疗糖尿病的中药的制备方法，不仅具有治疗糖尿病的作用，因为其采用纯中药制作，所以还具有中药的其他作用，例如：
旱莲草：旱莲草有滋补肝肾，乌须固齿，凉血止血的功效，旱莲草主治肝肾不足，眩晕耳鸣，视物昏花，腰膝酸软，发白齿摇，劳淋带浊，咯血，吐血，衄血，尿血，血痢，崩漏，外伤出血。
女贞子：滋补肝肾、明目乌发。属补虚药分类下的补阴药。
莬丝子：具有补肝肾，益精髓，明目，治腰膝酸痛，遗精，消渴，尿有余沥，目暗，为补肾缩尿，止遗精之常用药，用于肝肾不足之腰膝酸痛、阳痿、遗精。本品性柔润，平补肝肾而不燥。
柴胡：清热解毒，活血利白花蛇舌草尿，用于扁桃体炎、咽喉炎、尿路感染、盆腔炎、阑尾炎、肝炎、菌痢、毒蛇咬伤、肿瘤，能增强机体的免疫力，抑制肿瘤细胞的生长。
白芍：具有柔肝止痛，胁痛，镇静抗菌，养血敛阴，收汗等功能。
土茯苓：具有除湿解毒，用于筋骨挛痛有显著的效果。
以本发明实施例制得的治疗糖尿病的中药随机对几种症状的患者进行治疗，得到的数据如下：
Figure PCTCN2020077786-appb-000001
Figure PCTCN2020077786-appb-000002
此外，从上述对比及内容可以得知，本发明采用的配方和制备工艺，使得中药组合物的精华液成分对糖尿病患者的治疗效果更佳；此外，由该中药组合物在具有非常好的渗透性，，增强了食欲，因此对厌食症患者有一定的治疗效果。
本发明提供了一种用于治疗糖尿病的中药，其原料按重量份如下：旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25。本发明与常规治疗糖尿病的方法相比，采用中药材治疗，无毒副作用，而且不会损伤人体，治疗方便，服用一段时间，可明显减轻糖尿病引起的全身并发症的现象。

Claims (5)

  1. 一种用于治疗糖尿病的中药，其特征在于：其原料按重量份如下：旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25。
  2. 根据权利要求1所述的一种用于治疗糖尿病的中药，其特征在于：所述旱莲草、女贞子、菟丝子、柴胡、陈皮、青皮、积壳、白术、白芍、黄柏、郁金、熟地、鳖甲、金钱龟板重量份比例为可按糖尿病患者身体所出现的单纯病症、并发症、合病等在原药方不变的前提下作不同重量比例配伍。
  3. 根据权利要求1所述一种用于治疗糖尿病的中药的制备方法，其特征在于：包括如下步骤：S1：按照重量份取中药原料，去除霉坏的中药材，再将中药材清洗干净，并自然风干使水含量于5至8％；S2：清洗后将中药材原料分别置于粉碎机内粉碎处理，粉碎后过50至100目网，并将粉碎后的中药材分别置于不同的密闭等重量的不锈钢罐体内，向该不锈钢罐体按照的重量旱莲草30份、女贞子30份、菟丝子15份、柴胡15份、陈皮10份、青皮10份、积壳5份、白术15份、白芍10份、黄柏10份、郁金15份、熟地15份、鳖甲25份、金钱龟板25份关系添加中药材；S3：将S2中不锈钢罐体内的中药材一同加入混料机中，混合10分钟；S4：采用灌装机将混合后的中药材等重量的灌装入干净的包装袋中，并使用真空包装机包装封口。
  4. 根据权利要求3所述一种用于治疗糖尿病的中药的制备方法，其特征在于：所述不锈钢罐体使用后清洗干净并用紫外线照射10-20min，照射后立即用盖子密封，避免灰尘、细菌进入。
  5. 根据权利要求3所述一种用于治疗糖尿病的中药的制备方法，其特征在于：S4中包装结束后检查包装袋是否包装完好，未包装完好的包装带重新包装。
PCT/CN2020/077786 2019-04-17 2020-03-04 一种用于治疗糖尿病的中药及其制备方法 WO2020211556A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910306121.1A CN111346196A (zh) 2019-04-17 2019-04-17 一种用于治疗糖尿病的中药及其制备方法
CN201910306121.1 2019-04-17

Publications (1)

Publication Number Publication Date
WO2020211556A1 true WO2020211556A1 (zh) 2020-10-22

Family

ID=71192102

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/077786 WO2020211556A1 (zh) 2019-04-17 2020-03-04 一种用于治疗糖尿病的中药及其制备方法

Country Status (2)

Country Link
CN (1) CN111346196A (zh)
WO (1) WO2020211556A1 (zh)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108743783A (zh) * 2018-08-29 2018-11-06 齐爱萍 一种治疗糖尿病的中药

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089789A (zh) * 1993-01-13 1994-07-27 蒋金都 病食佳系列食品的制备方法
CN103566172A (zh) * 2013-11-27 2014-02-12 妮娜·贾尔肯 一种治疗肾气亏损性糖尿病的哈萨克药物组合与制备方法
CN103800689A (zh) * 2014-02-20 2014-05-21 丁常燕 一种治疗糖尿病的中药组合物
CN108042721A (zh) * 2017-04-16 2018-05-18 赵仁多 中药消渴汤
CN108096504A (zh) * 2017-12-14 2018-06-01 珠海横琴新区德群中医药科学研究院有限公司 一种用于治疗肝癌的中药

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108743783A (zh) * 2018-08-29 2018-11-06 齐爱萍 一种治疗糖尿病的中药

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GAO, JING : "Ligustrum Lucidum and Eclipta Prostrata-Erzhi Pill", TREATING DISEASE WITH SIMPLE PRESCRIPTION-PROFESSOR LU RENHE'S SIMPLE PRESCRIPTION FOR TREATING NEPHROPATHY, 31 December 2015 (2015-12-31), CN, pages 1 - 4, XP009523847 *
LIN, YUPING ET AL: "Professor Fan Guanjie's Experience in Treating Diabetes with Shugan Drugs", SHI ZHEN GUO YI GUO YAO - LIGUSTRUM LUCIDUM AND ECLIPTA PROSTRATA-ERZHI PILL, vol. 25, no. 11, 20 November 2014 (2014-11-20), pages 2779 - 2780, XP009523848, ISSN: 1008-0805 *
MONA; QIAO XIAOYAN;: "Analysis of Insulin Resistance of Traditional Chinese Medicine in Treating Type 2 Diabetes", SHAANXI JOURNAL OF TRADITIONAL CHINESE MEDICINE, vol. 30, no. 01, 5 January 2009 (2009-01-05), pages 88 - 90, XP009523707, ISSN: 1002-168X *

Also Published As

Publication number Publication date
CN111346196A (zh) 2020-06-30

Similar Documents

Publication Publication Date Title
CN103656558A (zh) 一种清心凉茶中药组合物及其制备方法
CN1228066C (zh) 十八味补肾益气口服液及制备方法
CN101011544A (zh) 痛风速康颗粒(胶囊)及其制作工艺
CN104258292A (zh) 一种治疗妊娠合并症的妇产科药物及其制作方法
CN108635544A (zh) 治疗桥本氏甲状腺炎中药组合物及其制备方法和应用
CN101023992B (zh) 治疗乳腺增生病的药物
CN102813749A (zh) 一种前列腺养护与治疗的药液
CN104225502A (zh) 一种治疗内分泌失调的妇产科药物及其制作方法
CN100376280C (zh) 一种组合物在制备止血中药制剂中的应用
CN100376277C (zh) 一种复合中药组合物在制备防治衄血的药品中的应用
WO2020211556A1 (zh) 一种用于治疗糖尿病的中药及其制备方法
CN1052889C (zh) 一种治疗肝炎的中成药
CN100376279C (zh) 防治暑湿泄泻药食两用中药及制造方法
CN1517115A (zh) 治疗慢性盆腔炎的中成药——妇炎胶囊
CN100376278C (zh) 一种组合物在制备防治吐血的药品中的应用
CN103212030A (zh) 一种治疗肝郁型乳腺增生的中药及制备方法
CN111329927B (zh) 一种治疗女性特发性水肿的中药
CN100389805C (zh) 防治痢疾药食两用中药及制造方法
CN106822697B (zh) 通便中药及使用该中药的制剂及制备方法
CN101264208A (zh) 用于治疗胃肠功能紊乱的药物组合物及其制备方法
CN100423764C (zh) 一种内服用于治疗肿瘤的中药组合物
CN105998448A (zh) 提高免疫力的桑葚口服液制备方法及其口服液
CN100358576C (zh) 防治酒精中毒的中药及其制造方法
CN105521384A (zh) 一种治疗妊娠合并症的妇产科药物及其制作方法
CN105833094A (zh) 一种治疗沙眼的中药组合物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20790585

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20790585

Country of ref document: EP

Kind code of ref document: A1